A patent was approved August 3, 2019 The provisional US patent 62/804,903, named “Archetypal Defect Classes of Functional Vision Loss in Glaucoma to Diagnose Glaucomatous Vision Loss and its Progression” was approved. The inventors are Jorryt Tichelaar, Mengyu Wang, and Tobias Elze.